FR2283134A1 - Intermediaires de synthese de prostaglandines - Google Patents

Intermediaires de synthese de prostaglandines

Info

Publication number
FR2283134A1
FR2283134A1 FR7536204A FR7536204A FR2283134A1 FR 2283134 A1 FR2283134 A1 FR 2283134A1 FR 7536204 A FR7536204 A FR 7536204A FR 7536204 A FR7536204 A FR 7536204A FR 2283134 A1 FR2283134 A1 FR 2283134A1
Authority
FR
France
Prior art keywords
alpha
double
prostaglandin
thp
cis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7536204A
Other languages
English (en)
French (fr)
Other versions
FR2283134B1 (xx
Inventor
Hans-Jurgen Ernst Hess
Thomas Ken Schaaf
Leonard Joseph Czuba
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of FR2283134A1 publication Critical patent/FR2283134A1/fr
Application granted granted Critical
Publication of FR2283134B1 publication Critical patent/FR2283134B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7536204A 1971-09-01 1975-11-26 Intermediaires de synthese de prostaglandines Granted FR2283134A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17710271A 1971-09-01 1971-09-01

Publications (2)

Publication Number Publication Date
FR2283134A1 true FR2283134A1 (fr) 1976-03-26
FR2283134B1 FR2283134B1 (xx) 1978-05-12

Family

ID=22647201

Family Applications (3)

Application Number Title Priority Date Filing Date
FR7536205A Granted FR2283147A1 (fr) 1971-09-01 1975-11-26 Bromure de 4-(tetrazol-5-yl)-butyltriphenyl-phosphonium
FR7536203A Granted FR2283136A1 (fr) 1971-09-01 1975-11-26 Intermediaires de synthese de derives tetrazolyliques de prostaglandines
FR7536204A Granted FR2283134A1 (fr) 1971-09-01 1975-11-26 Intermediaires de synthese de prostaglandines

Family Applications Before (2)

Application Number Title Priority Date Filing Date
FR7536205A Granted FR2283147A1 (fr) 1971-09-01 1975-11-26 Bromure de 4-(tetrazol-5-yl)-butyltriphenyl-phosphonium
FR7536203A Granted FR2283136A1 (fr) 1971-09-01 1975-11-26 Intermediaires de synthese de derives tetrazolyliques de prostaglandines

Country Status (12)

Country Link
JP (1) JPS5724348B2 (xx)
AR (4) AR197304A1 (xx)
AT (3) AT335079B (xx)
CA (1) CA978939A (xx)
DK (1) DK144730C (xx)
ES (3) ES406250A1 (xx)
FI (1) FI55497C (xx)
FR (3) FR2283147A1 (xx)
IL (3) IL40183A (xx)
PH (3) PH10023A (xx)
SE (4) SE409032B (xx)
ZA (1) ZA725827B (xx)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Also Published As

Publication number Publication date
PH10443A (en) 1977-03-25
PH10023A (en) 1976-07-13
AR199573A1 (es) 1974-09-13
AR199574A1 (es) 1974-09-13
IL48544A (en) 1977-06-30
ES417558A1 (es) 1976-06-16
IL48544A0 (en) 1976-01-30
SE409032B (sv) 1979-07-23
AR199784A1 (es) 1974-09-30
FR2283136B1 (xx) 1978-05-12
SE7606690L (sv) 1976-06-11
ES417557A1 (es) 1976-06-16
AR197304A1 (es) 1974-03-29
FR2283147B1 (xx) 1978-05-12
AT335079B (de) 1977-02-25
SE7606689L (sv) 1976-06-11
ATA51974A (de) 1975-04-15
IL40183A (en) 1977-06-30
SE421526B (sv) 1982-01-04
JPS5724348B2 (xx) 1982-05-24
CA978939A (en) 1975-12-02
SE7606691L (sv) 1976-06-11
DK144730B (da) 1982-05-24
SE424185B (sv) 1982-07-05
FI55497C (fi) 1979-08-10
ES406250A1 (es) 1976-06-01
IL40183A0 (en) 1972-10-29
FR2283136A1 (fr) 1976-03-26
ZA725827B (en) 1973-06-27
FI55497B (fi) 1979-04-30
DK144730C (da) 1982-10-18
JPS4834165A (xx) 1973-05-16
SE421525B (sv) 1982-01-04
AT327219B (de) 1976-01-26
FR2283134B1 (xx) 1978-05-12
FR2283147A1 (fr) 1976-03-26
PH10416A (en) 1977-03-16
ATA743472A (de) 1976-06-15

Similar Documents

Publication Publication Date Title
US4304907A (en) Bicyclo lactone intermediates for prostaglandin analogs
US4668814A (en) Interphenylene carbacyclin derivatives
FR2283134A1 (fr) Intermediaires de synthese de prostaglandines
US3823138A (en) Lactone intermediates
US3965118A (en) Lactone intermediates
US3845115A (en) 15-lower alkoxy pgf compounds
US4487960A (en) 9-Substituted carbacyclin analogs
US4312810A (en) 2,5-Inter-o-phenylene-3,4-dinor-5,9α-epoxy-9-deoxy-PGF1 compounds
US3892792A (en) Process for the synthesis of PGE compounds from PGF compounds
CA1047491A (en) Prostaglandin-type compounds and process for their preparation
US4029693A (en) 2A,2B-Dihomo-11-deoxy-17(substituted phenyl)-18,19,20-trinor-PGE2 compounds and their corresponding esters
US3969381A (en) 13,14-Dihydro-16-fluoro prostaglandin B1 analogs
US3822303A (en) Trimethyl silyl esters of prostaglandin e acids and esters and process therefor
US4130721A (en) 11-Deoxy PGE2 compounds
US3969376A (en) 13,14-Dihydro-16-fluoro prostaglandin E1 analogs
DE3142733A1 (de) Verfahren zur herstellung von carbacyclin-zwischenprodukten
US3853950A (en) 15-lower alkoxy pga compounds
US3835180A (en) 15 alkoxy pge compounds
US3847966A (en) Prostaglandin e1,f1,and a1 analogs
US3969377A (en) 16-Fluoro prostaglandin E1 analogs
US4151351A (en) 7,8-Didehydro-PGI1 compounds
US3880887A (en) Bicyclic lactones
US4259479A (en) 2-Decarboxy-2-aminomethyl-4-halo-5,9-epoxy-9-deoxy-PGF1 compounds
US3927075A (en) PGF{HD 2{301 {B {0 and PGF{HD 2{331 {B , 15-acetate, methyl esters
NL8001318A (nl) Tromboxaananaloga.

Legal Events

Date Code Title Description
ST Notification of lapse